COSCIENS Biopharma Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $21.4M
Liabilities Breakdown FY2025
Total Liabilities: $17.6M
Asset Breakdown
Total Assets: $21.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $7.3M | 34.1% |
| Accounts Receivable | $1.3M | 5.9% |
| Inventory | $1.3M | 6.1% |
| Property, Plant & Equipment | $1.9M | 8.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $9.7M | 45.3% |
Liabilities Breakdown
Total Liabilities: $17.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $17.6M | 100.0% |